Key facts
- This page summarizes Juan Andres's Form 4 filing for Moderna, Inc. (MRNA).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 30 Dec 2022, 15:31.
Juan Andres - 28 Dec 2022 Form 4 Insider Report for Moderna, Inc. (MRNA)
- Reporting relationship
- Chief Technical Operations and Quality Officer
- Issuer ticker
- MRNA
- Reported as of
- 28 Dec 2022
- Net transaction value
- -$318,140
- SEC form
- 4
- Accepted by SEC
- 30 Dec 2022, 15:31:18 UTC
- Prior SEC filing
- 23 Dec 2022
- Next SEC filing
- 15 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brian Sandstrom, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Juan Andres filed Form 4 for Moderna, Inc. (MRNA) on 30 Dec 2022.
Change
- Previous filing in this sequence was filed on 23 Dec 2022.
- Current net transaction value: -$318,140.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MRNA
transaction
Common Stock
Options Exercise
- Transaction value
- $41,860
- Shares
- +2,000
- Change %
- +16%
- Price
- $20.93*
- Shares after
- 14,803
- Date
- 28 Dec 2022
- Ownership
- Direct
- Footnotes
- F1
MRNA
transaction
Common Stock
Sale
- Transaction value
- $360,000
- Shares
- -2,000
- Change %
- -14%
- Price
- $180.00
- Shares after
- 12,803
- Date
- 28 Dec 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MRNA
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -2,000
- Change %
- -0.98%
- Price
- $0.000000
- Shares after
- 203,025
- Date
- 28 Dec 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,000
- Exercise price
- $20.93
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Juan Andres is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 2 footnotes
Footnote F1
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 19, 2021.
Footnote F2
25% of this option vested and became exercisable on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
SEC remarks
Chief Technical Operations and Quality Officer